LY2886721 is an oral, small molecule of beta-site amyloid protein cleaving enzyme (BACE) inhibitor with the potential to inhibit the synthesis of beta-amyloid and thereby to slow the clinical progression of AD. More information please visit the website: http://www.creative-enzymes.com/product/LY2886721_2349.html
View Contact Detail